Nammi Therapeutics, Inc. Completes Series B Round with Investment from MMRF’s Myeloma Investment Fund; Advances Clinical Development of Lead Program, QXL138AM
August 6, 2024
View
Updates in MM From ASCO 2024 and EHA 2024
August 2, 2024
Myeloma Investment Fund Invests in Envisagenics, A.I.-Driven Biotechnology Company
July 29, 2024
Meet Team Papa JJ (In honor of Douglas J.J. Peters), MMRF 2024 Walk/Run: Washington, D.C. Spirit of Hope Honoree
July 25, 2024
Statement on former MMRF Board Member and basketball legend Pat Williams
July 18, 2024
Myeloma Investment Fund Invests in Dynamic Cell Therapies to Help Fuel Novel CAR T-Cell Technologies
July 11, 2024
Discovering new biology and vulnerabilities in high-risk disease from the MMRF CoMMpass study
July 2, 2024
Myeloma Family Spotlight
June 27, 2024
EHA 2024 Myeloma Oral Sessions Day 1
June 14, 2024
ASCO 2024 Myeloma Oral Sessions Day 3
June 6, 2024
Meet Dennis McClure MMRF 2024 Walk/Run: Dallas Spirit of Hope Honoree and member of the North Texas Myeloma Support Group (NTMSG)
ASCO 2024 Myeloma Oral Sessions Day 2
June 5, 2024
Knowledge is power. Sign up today and we’ll help you stay informed.
sign up
We value your privacy.
Get Your Free Toolkit